Clinical trials
Phase 2 Leukemia, Myeloid, Acute trials in Denmark
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2010 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Recruiting | 2 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fred Hutchinson Cancer Center | 2 |
| Astellas Pharma Global Development, Inc. | 1 |
| Astex Pharmaceuticals, Inc. | 1 |
| Celgene | 1 |
| Karyopharm Therapeutics Inc | 1 |
| Kirsten Grønbæk | 1 |
| Rigshospitalet, Denmark | 1 |
| Sanofi | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myeloid, Acute | 9 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 |
| Hodgkin Disease | 2 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 |
| Lymphoma, Large B-Cell, Diffuse | 2 |
| Lymphoma, Mantle-Cell | 2 |
| Lymphoma, Non-Hodgkin | 2 |
| Multiple Myeloma | 2 |
| Waldenstrom Macroglobulinemia | 2 |
| Anemia, Refractory, with Excess of Blasts | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.